NCT06244537View on ClinicalTrials.gov

Study on the Safety and Efficacy of MR-Linac Technique in Patients With Unresectable Locally Advanced Colon Cancer

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

December 30, 2027

Study Completion Date

December 31, 2027

Conditions
Safety and Efficacy
Interventions
RADIATION

MR-linac

Patients enrolled will be treated with MR-Linac with short course radiotherapy (25Gy/5F), followed by 4 cycles of mFOLFOX6 or 3 cycles of XELOX chemotherapy, then radical surgical resection, and then postoperatively with 8 cycles of mFOLFOX6 or 5 cycles of XELOX chemotherapy.

Trial Locations (1)

610042

RECRUITING

Sichuan Cancer Hospital & Institute, Affiliated Cancer Hospital of University of Electronic Science and Technology of China., Chengdu

All Listed Sponsors
lead

Sichuan Cancer Hospital and Research Institute

OTHER